Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas

NCT00640822 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00640822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2009
Enrollment
782 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris